“One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects”
More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University of Chicago have discovered that selectively blocking a serotonin receptor subtype induces fast-acting antidepressant effects in mice, indicating a potential new class of therapeutics for depression. The work was published Oct. 29 in Molecular Psychiatry.
“One of the biggest problems in the treatment of depression today is a delay in onset of therapeutic effects. There has been a great need to discover faster-acting drugs,” said Stephanie Dulawa, PhD, associate professor of psychiatry and behavioral neuroscience at the University of Chicago and senior author of the study.
Delayed onset of antidepressant therapeutics can significantly impact patients, especially those with major depressive disorder, who often spend months switching between ineffective medications. Currently, only two drugs—ketamine and scopolamine—exhibit rapid onset. Due to severe side effects, however, neither is suitable for human use.
In seeking a new class of fast-acting therapeutics, Dulawa and her team tested biological pathways that had previously been shown to generate antidepressant effects but had never been studied for rate of onset. They looked at different subtypes of serotonin receptors, proteins that are binding partners for serotonin, a neurotransmitter that has been shown to regulate mood, memory and appetite.
Of these subtypes, serotonin 2C receptors stood out. Selectively blocking these receptors in mice significantly reduced depression-like behaviors in only five days, compared to a minimum of two weeks for a control antidepressant medication.
“We observed fast-acting therapeutic effects in multiple behavioral tasks after we administered compounds that selectively block serotonin 2C receptors,” said Mark Opal, a graduate student at the University of Chicago and lead author of the paper. “We began our measurements at five days, but we think there’s a possibility it could be effective even sooner than that.”
Serotonin 2C receptors normally inhibit the release of dopamine, another neurotransmitter commonly associated with mood, from certain neurons. When 2C is blocked, the researchers believe, more dopamine is released into regions of the brain such as the prefrontal cortex. The team also observed the induction of biomarkers that indicate antidepressant action.
This is the first new biological mechanism that has shown the ability to rapidly alleviate symptoms of depression since ketamine and scopolamine, and it potentially represents a much safer alternative.
Go deeper with Bing News on:
- Psychology Todayon January 12, 2021 at 3:59 pm
Pharmaceutical giant Johnson & Johnson gained U.S. Food and Drug Administration (FDA) approval in 2019 for its fast-acting antidepressant chemical compound that mirrors ketamine. “The regulatory ...
- Depression Resource Center Newson January 11, 2021 at 4:00 pm
Medscape Medical News, September 30, 2010 ACEP Ketamine Offers Fast-Acting Alleviation of Acute Depression in ED Setting A single intravenous bolus dose of ketamine offered rapid alleviation of ...
- Tal Medical Gets NIMH Backing for Fast-Acting Depression Therapyon January 9, 2021 at 3:59 pm
If you’re suffering from depression, then going to a doctor’s office, sticking your head into a magnetic coil and getting your brain electronically stimulated might not seem all that appetizing.
- Synthetic Psychedelic Treats Depression Without Hallucinationson January 5, 2021 at 9:42 am
Further studies with mice have shown that the drug has similar antidepressant effects in mice as ketamine, providing both fast-acting and effective relief. In the midst of this, they also found that ...
- Flicking Epigenetic Switches May Create Fast-Acting Antidepressantson January 5, 2021 at 1:30 am
Assessing the ability of unresponsive patients with severe brain injury to understand what is being said to them could yield important insights into how they might recover, according to new research.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- What it’s like to realise you might need antidepressantson January 17, 2021 at 3:07 pm
‘I have no plans to come off my medicine and have been taking it for years’ (Picture: Getty) Medication is often the first suggestion someone will bring to the table when told about a mental ...
- Antidepressants Market Overview 2023, Key Manufactures, Types and Application, New Trends, Market Share, Key Developments, Challenges and Riskon January 11, 2021 at 10:06 pm
Jan 12, 2021 (The Expresswire) -- The “Antidepressants Market” report offers important information on the business overview, market trends, product services, market size and share, growth rate ...
- Help! Antidepressants Have Made My Wife Too Cheery.on January 10, 2021 at 5:34 am
Our advice columnists have heard it all over the years. Each Sunday, we will be diving into the Dear Prudie archives and sharing a selection of classic letters with our readers. I have been with ...
- ‘The pandemic took all my coping mechanisms away’: The people who started antidepressants during lockdownon January 9, 2021 at 6:56 am
After a positive experience herself with antidepressants, she encouraged Siobhan to contact her GP. Upon waking the next day, Siobhan realised something needed to change and called her doctor to ...
- ‘In August, during a tearful phone call with a locum in my doctor’s office, I asked for a prescription for antidepressants’on January 8, 2021 at 6:51 pm
In August, during a tearful phone call with a locum in my doctor’s office, I asked for a prescription for antidepressants. I’d been feeling bad for a long time. Four years at least.